(VIANEWS) – Fomento Economico Mexicano S.A.B. de C.V. (FMX), Imax Corporation (IMAX), Ingersoll (IR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Fomento Economico Mexicano S.A.B. de C.V. (FMX)
24.1% sales growth and 13.28% return on equity
Fomento Económico Mexicano, S.A.B. de C.V., through its subsidiaries, operates as a bottler of Coca-Cola trademark beverages. The company produces, markets, and distributes Coca-Cola trademark beverages in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil, Argentina, and Uruguay. It also operates small-box retail chain stores in Mexico, Colombia, Peru, Chile, and Brazil under the OXXO name; retail service stations for fuels, motor oils, lubricants, and car care products under the OXXO GAS name in Mexico; and drugstores in Chile, Colombia, Ecuador, and Mexico under the Cruz Verde, Fybeca, SanaSana, YZA, La Moderna, and Farmacon names. In addition, the company is involved in the production and distribution of collers, commercial refrigeration equipment, plastic boxes, food processing, and preservation and weighing equipment; and provision of logistic transportation, distribution and maintenance, point-of-sale refrigeration, and plastics solutions, as well as distribution platform for cleaning products and consumables. Further, it operates small-box retail and food convenience chain stores in Switzerland, Germany, Austria, Luxembourg, and the Netherlands under the k kiosk, Brezelkönig, BackWerk, Ditsch, Press & Books, avec, Caffè Spettacolo, and ok.–) names, as well as pretzels under the Ditsch name. The company was founded in 1890 and is based in Monterrey, Mexico.
Earnings Per Share
As for profitability, Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months EPS of $3.85.
PE Ratio
Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months price to earnings ratio of 30.36. Meaning, the purchaser of the share is investing $30.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.28%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.3%, now sitting on 736.02B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 0.7% and positive 132.4% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Fomento Economico Mexicano S.A.B. de C.V.’s EBITDA is 0.29.
2. Imax Corporation (IMAX)
16.8% sales growth and 3.18% return on equity
IMAX Corporation, together with its subsidiaries, operates as an entertainment technology company that specializes in digital and film-based motion picture technologies worldwide. It offers cinematic solution comprising proprietary software, theater architecture, intellectual property, and equipment. The company offers Digital Re-Mastering (DMR), a proprietary technology that digitally enhances the image resolution, visual clarity, and sound quality of motion picture films for projection on IMAX screens; IMAX premium theater systems to exhibitor customers through sales, long-term leases, and joint revenue sharing arrangements; film post-production services; and camera and other miscellaneous items rental services, as well as distributes documentary films; and owns and operates IMAX theaters. It also designs, manufactures, installs, sells, and leases IMAX theater projection system equipment; maintains IMAX theater projection system equipment in the IMAX theater network; distributes and licenses original content, virtual reality, IMAX home entertainment, and others; and sells or leases its theater systems to theme parks, private home theaters, tourist destination sites, fairs, and expositions, as well as engages in the after-market sale of projection system parts and 3D glasses. The company markets its theater systems through a direct sales force and marketing staff. It owns or otherwise has rights to trademarks and trade names, which include IMAX, IMAX Dome, IMAX 3D, IMAX 3D Dome, Experience It in IMAX, The IMAX Experience, An IMAX Experience, An IMAX 3D Experience, IMAX DMR, DMR, IMAX nXos, and Films To The Fullest. As of March 31, 2020, the company had a network of 1,616 IMAX theater systems comprising 1,526 commercial multiplexes, 14 commercial destinations, and 76 institutional facilities operating in 81 countries and territories. IMAX Corporation was founded in 1967 and is headquartered in Mississauga, Canada.
Earnings Per Share
As for profitability, Imax Corporation has a trailing twelve months EPS of $-0.13.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.18%.
3. Ingersoll (IR)
9% sales growth and 7.57% return on equity
Ingersoll Rand Inc. provides various mission-critical air, fluid, energy, specialty vehicle, and medical technologies in the United States, Europe, the Middle East, India, Africa, and the Asia Pacific. It operates through two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services air and gas compression, vacuum, and blower products; fluid transfer equipment and loading systems; and power tools and lifting equipment, including associated aftermarket parts, consumables, air treatment equipment, controls, other accessories, and services under the under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, Robuschi, Emco Wheaton, and Runtech Systems brands. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, automated liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for liquid and gas dosing, transfer, dispensing, compression, sampling, pressure management, and flow control in specialized or critical applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brand names. This segment's products are used in medical, life sciences, industrial manufacturing, water and waste water, chemical processing, energy, food and beverage, agriculture, and other markets. It sells through an integrated network of direct sales representatives and independent distributors. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina.
Earnings Per Share
As for profitability, Ingersoll has a trailing twelve months EPS of $1.67.
PE Ratio
Ingersoll has a trailing twelve months price to earnings ratio of 41.35. Meaning, the purchaser of the share is investing $41.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.57%.
Volume
Today’s last reported volume for Ingersoll is 1148390 which is 48.07% below its average volume of 2211700.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Ingersoll’s EBITDA is 4.41.
Yearly Top and Bottom Value
Ingersoll’s stock is valued at $69.06 at 06:22 EST, higher than its 52-week high of $68.92.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 21, 2023, the estimated forward annual dividend rate is 0.08 and the estimated forward annual dividend yield is 0.12%.
Previous days news about Ingersoll(IR)
- According to Zacks on Thursday, 24 August, "Zacks Rank #2 Ingersoll Rand has an expected revenue and earnings growth rate of 14.5% and 16.5%, respectively, for the current year. "
- According to Zacks on Thursday, 24 August, "Companies like Ingersoll Rand (IR Quick QuoteIR – Free Report) , RBC Bearings (RBC Quick QuoteRBC – Free Report) , Flowserve Corporation (FLS Quick QuoteFLS – Free Report) and Graham Corporation (GHM Quick QuoteGHM – Free Report) are well-placed to capitalize on the buoyancy in the industry.", "Ingersoll Rand: Headquartered in Davidson, NC, Ingersoll Rand is a global industrial company, with expertise in industrial and mission-critical flow creation technologies. "
- Zacks industry outlook highlights ingersoll rand, RBC bearings, flowserve and graham. According to Zacks on Friday, 25 August, "The Zacks Consensus Estimate for Ingersoll Rand’s 2023 earnings has been revised upward by 1.5% in the past 60 days. ", "Ingersoll Rand: Headquartered in Davidson, NC, Ingersoll Rand is a global industrial company, with expertise in industrial and mission-critical flow creation technologies. "
4. Semler Scientific (SMLR)
8.2% sales growth and 28.82% return on equity
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
Earnings Per Share
As for profitability, Semler Scientific has a trailing twelve months EPS of $1.92.
PE Ratio
Semler Scientific has a trailing twelve months price to earnings ratio of 12.43. Meaning, the purchaser of the share is investing $12.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.82%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 9.8% and 6.5%, respectively.
Sales Growth
Semler Scientific’s sales growth is 7.9% for the present quarter and 8.2% for the next.
Volume
Today’s last reported volume for Semler Scientific is 33833 which is 32.01% below its average volume of 49766.
Yearly Top and Bottom Value
Semler Scientific’s stock is valued at $23.86 at 06:22 EST, way below its 52-week high of $46.31 and way above its 52-week low of $19.12.
5. International General Insurance Holdings Ltd. (IGIC)
8% sales growth and 23.67% return on equity
International General Insurance Holdings Ltd. provides specialty insurance and reinsurance solutions worldwide. The company operates through three segments: Specialty Long-tail, Specialty Short-tail, and Reinsurance segments. It offers a portfolio of specialty lines insurance products and services for energy, property, construction and engineering, ports and terminals, general aviation, political violence, casualty, financial institutions, marine liability, and treaty reinsurance. The company was founded in 2001 and is based in Amman, Jordan.
Earnings Per Share
As for profitability, International General Insurance Holdings Ltd. has a trailing twelve months EPS of $1.98.
PE Ratio
International General Insurance Holdings Ltd. has a trailing twelve months price to earnings ratio of 4.86. Meaning, the purchaser of the share is investing $4.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.67%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 31.4%, now sitting on 453.12M for the twelve trailing months.
Sales Growth
International General Insurance Holdings Ltd.’s sales growth is 7% for the current quarter and 8% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 3.3% and a negative 14.3%, respectively.
6. CVS Health (CVS)
7.8% sales growth and 3.81% return on equity
CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Earnings Per Share
As for profitability, CVS Health has a trailing twelve months EPS of $2.19.
PE Ratio
CVS Health has a trailing twelve months price to earnings ratio of 30.83. Meaning, the purchaser of the share is investing $30.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.81%.
Yearly Top and Bottom Value
CVS Health’s stock is valued at $67.52 at 06:22 EST, way below its 52-week high of $104.83 and above its 52-week low of $64.62.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 1.9% and 3.5%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
CVS Health’s EBITDA is 0.45.
Sales Growth
CVS Health’s sales growth is 8.7% for the present quarter and 7.8% for the next.
Previous days news about CVS Health(CVS)
- The zacks analyst blog highlights Merck, philip morris, QUALCOMM, CVS health and chubb. According to Zacks on Thursday, 24 August, "Stocks recently featured in the blog include: Merck & Co., Inc. (MRK Quick QuoteMRK – Free Report) , Philip Morris International Inc. (PM Quick QuotePM – Free Report) , Qualcomm Inc. (QCOM Quick QuoteQCOM – Free Report) , CVS Health Corporation (CVS Quick QuoteCVS – Free Report) and Chubb Limited (CB Quick QuoteCB – Free Report) .", "Rising geopolitical volatility and high debt burden remain headwinds.(You can read the full research report on QUALCOMM here >>>)Other noteworthy reports we are featuring today include CVS Health Corporation and Chubb Limited."
- CVS health's (cvs) cordavis to focus on biosimilar products. According to Zacks on Thursday, 24 August, "In June 2023, CVS Health opened a Workforce Innovation and Talent Center in collaboration with the Goodwill Industries of Greater Detroit. ", "Through Cordavis, CVS Health aims to develop a portfolio of products that will potentially facilitate broader access to biosimilars in the United States. "
